2001
DOI: 10.3892/ijmm.8.3.265
|View full text |Cite
|
Sign up to set email alerts
|

Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
35
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(38 citation statements)
references
References 0 publications
3
35
0
Order By: Relevance
“…Our study of quail CAM under two experimental conditions clearly demonstrated that leptin enhanced the formation of new blood vessels. The results are in accordance with the data obtained using chicken CAM (Bouloumié et al 1998;Ribatti et al 2001). Bouloumié et al (1998) applied leptin at ED9 at higher doses (0.2, 1, and 3 µg of leptin) onto methylcellulose discs.…”
Section: Discussionsupporting
confidence: 82%
“…Our study of quail CAM under two experimental conditions clearly demonstrated that leptin enhanced the formation of new blood vessels. The results are in accordance with the data obtained using chicken CAM (Bouloumié et al 1998;Ribatti et al 2001). Bouloumié et al (1998) applied leptin at ED9 at higher doses (0.2, 1, and 3 µg of leptin) onto methylcellulose discs.…”
Section: Discussionsupporting
confidence: 82%
“…Growth factor Esch et al (1985) Basic fibroblast growth factor (bFGF) or Wilting et al (1991) Fibroblast growth factor-2 (FGF-2) Olivo et al (1992) Ribatti et al (1995) Fett et al (1985 Angiogenin Wilting et al (1991) Olivo et al (1992 Leibovich et al (1987) Tumor necrosis factor alpha (TNF-␣) Olivo et al (1992) Yang andMoses (1990) Transforming growth factor beta (TGF-␤) Wilting et al (1992) Platelet derived growth factor (PDGF) Wilting et al (1992Wilting et al ( , 1993 Vascular endothelial growth factor (VEGF) Ziche et al (1997) Placenta growth factor-1 (PIGF-1) Bouloumie et al (1998) Leptin Ribatti et al (2001 Erythropoietin (EPO) Ramoshebi and Ripamonti (2000) Osteogenic protein-1 (OP-1) Bernardini et al (2000) CC chemokine I-309…”
Section: Authorsmentioning
confidence: 99%
“…IFN-a reduces urokinase-type plasminogen activator and plasminogen activator inhibitor-1 activity (135) and significantly inhibits MMP-9 enzymatic activity and protein expression (136). IFN-a and IFN-h treatment also inhibits angiogenesis by down-regulation of bFGF expression (137)(138)(139), but other studies suggest that the action of IFN-a is not mediated by bFGF or VEGF (140)(141)(142).…”
Section: Non-matrix-derived Inhibitors Of Angiogenesismentioning
confidence: 99%